ATLASInvesco Nasdaq Biotechnology ETF (IBBQ): outlook, holdings and fees
Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund and is managed by Invesco. The expense ratio is 0.18% and the yield is 1.15%. The ten largest holdings are 46% of the fund.
Fund data as of Oct 14, 2026 · Price Nov 2, 2026
ATLAS view on IBBQ
| Last price | $36.04 (-0.4%) |
|---|---|
| ATLAS chance of a higher price in 1 month | 52% |
| Likely 1-month range (50%) | $34.69 – $37.69 |
| Normal 1-day range (±1σ) | ±1.4% |
| Distribution yield | 1.15% |
ATLAS probabilities use the same calibrated model as every stock page. A fair value is shown for companies, not funds; the holdings below link to the fair value of each company.
IBBQ fund facts
| Issuer | Invesco |
|---|---|
| Theme | Technology & innovation |
| Assets under management | $108M |
| Expense ratio | 0.18% |
| Number of holdings | 50 |
| Portfolio turnover | 13% |
| Inception | Jun 11, 2021 |
| Exchange | NASDAQ |
The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified.
IBBQ top holdings
| Holding | Sector | Weight |
|---|---|---|
| Gilead Sciences Inc GILD | Healthcare | 8.06% |
| Amgen Inc AMGN | Healthcare | 7.92% |
| Vertex Pharmaceuticals Inc VRTX | Healthcare | 7.50% |
| Moderna Inc MRNA | Healthcare | 5.92% |
| Regeneron Pharmaceuticals Inc REGN | Healthcare | 4.85% |
| Illumina Inc ILMN | Healthcare | 2.72% |
| Revolution Medicines Inc RVMD | Healthcare | 2.80% |
| Biogen Inc BIIB | Healthcare | 2.16% |
| Alnylam Pharmaceuticals Inc ALNY | Healthcare | 2.01% |
| Roivant Sciences Ltd ROIV | Healthcare | 1.76% |
Holdings with an ATLAS page link to their probability range, fair value and earnings calendar.
IBBQ sector breakdown
| Sector | Weight |
|---|---|
| Healthcare | 100.0% |
By region: North America 95.5%, Europe Developed 2.4%, United Kingdom 1.9%.
IBBQ returns and risk
| Year to date | +19.5% |
|---|---|
| 1 year | +32.7% |
| 3 years (annualised) | +19.9% |
| 5 years (annualised) | +7.7% |
| 10 years (annualised) | 0.0% |
| Volatility (3 years) | 17.7% |
| Sharpe ratio (3 years) | 0.98 |
Past returns do not guarantee future results.
IBBQ: frequently asked questions
What does IBBQ invest in?
Invesco Nasdaq Biotechnology ETF invests in a portfolio of securities. Its largest holdings are Gilead Sciences Inc (8.1%), Amgen Inc (7.9%), Vertex Pharmaceuticals Inc (7.5%), Moderna Inc (5.9%), Regeneron Pharmaceuticals Inc (4.9%).
What is the IBBQ expense ratio?
0.18% a year: about $18.00 for every $10,000 invested.
What is the IBBQ dividend yield?
1.15%. ATLAS does not hold the exact distribution dates for ETFs.
Will IBBQ go up?
Nobody can know. The ATLAS model puts the chance of a higher price in one month at 52%, with a likely range (50%) of $34.69 to $37.69 from $36.04 today. It is a probability, not a prediction.
How has IBBQ performed?
Year to date +19.5%, one year +32.7%, three years +19.9% a year, five years +7.7% a year. Past returns do not guarantee future results.
Similar ETFs: Technology & innovation
- Vanguard Information Technology ETF (VGT)
- State Street Technology Select Sector SPDR ETF (XLK)
- iShares U.S. Technology ETF (IYW)
- Fidelity MSCI Information Technology Index ETF (FTEC)
- First Trust Nasdaq Cybersecurity ETF (CIBR)
- iShares Expanded Tech-Software Sector ETF (IGV)
- iShares A.I. Innovation and Tech Active ETF (BAI)
- iShares Expanded Tech Sector ETF (IGM)
Educational information, not investment advice. Disclaimer